Manipulation of Death Pathways in Desmin-Related Cardiomyopathy
Author(s) -
Alina Maloyan,
Jennifer Sayegh,
Hanna Osińska,
Balvin H.L. Chua,
Jeffrey Robbins
Publication year - 2010
Publication title -
circulation research
Language(s) - English
Resource type - Journals
eISSN - 1524-4571
pISSN - 0009-7330
DOI - 10.1161/circresaha.109.212639
Subject(s) - genetically modified mouse , desmin , apoptosis , autophagy , transgene , cardiomyopathy , downregulation and upregulation , programmed cell death , biology , mitochondrion , necrosis , cancer research , microbiology and biotechnology , myocyte , heart failure , medicine , immunohistochemistry , genetics , gene , vimentin
Accumulation of protein aggregates is a hallmark of several neurodegenerative disorders as well as for a number of protein conformation-based diseases, including those affecting muscle, liver and heart. Desminopathy or desmin-related myopathy (DRM) is a skeletal myopathy characterized by bilateral muscle weakness, but is often accompanied by cardiomyopathy as well. DRM can be caused by mutations in desmin, alphaB crystallin, myotilin, Z-band alternatively spliced PDZ-containing protein (ZASP), filamin C (FLNC) or Bcl-2-associated athanogene-3 (BAG3). The common pathological pattern in DRM is accumulation of misfolded proteins, however, clinical manifestations can differ significantly.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom